Arkolith/Insider Trading/ATRA/Form 4

Panacea Innovation Ltd

10% OwnerAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Mar 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2026Option exercise(M)259K—$0308K
Mar 17, 2026Tax withholding(F)5$5.23$26308K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 17, 2026Option exercise(M)259K$6.61$1.7M0

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-116060) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Atara Biotherapeutics, Inc.

Build

Ask your agent about ATRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-116060"
Ask your agent
Use Arkolith to summarize insider buying and selling at Atara Biotherapeutics, Inc.
over the last 90 days and cite the filings.